Kentucky Pediatric and Adult Research Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2007
NCT00419263
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

Kentucky Pediatric/Adult Research

Active Ingredients

Drugs in Phase 2 Trials (3)

antipyrine (1 trial)

benzocaine (Orajel) (1 trial)

peramivir (rapivab) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Influenza, Human (Phase 2)

Otitis (Phase 2)

Otitis Media (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 3